CORT vs MRNA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jun 28, 2026

CORT

59.4
AI Score
VS
CORT Wins

MRNA

56.8
AI Score

Investment Advisor Scores

CORT

59score
Recommendation
HOLD

MRNA

57score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CORT MRNA Winner
Forward P/E 100 23.0415 MRNA
PEG Ratio 0.813 0 Tie
Revenue Growth 4.9% 260.2% MRNA
Earnings Growth -21.6% -85.1% CORT
Tradestie Score 59.4/100 56.8/100 CORT
Profit Margin 6.2% -143.6% CORT
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Frequently Asked Questions

Based on our detailed analysis, CORT is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.